Although the left main coronary artery (LMCA) is clinically the most important site, little is known about the longitudinal plaque distribution and composition in the significant LMCA disease.
Preprocedure virtual histology intravascular ultrasound data were analyzed in 120 patients with significant LMCA bifurcation lesions (angiographic diameter stenosis>50%) requiring revascularization. Plaque burden and percentage of necrotic core (%NC) at the minimal lumen area site and maximal %NC site were measured in four segments: proximal LMCA, distal LMCA, left anterior descending (LAD) ostium, and proximal LAD.
Angiographically, a significant LMCA and ostial LAD stenosis were observed in 89.2 and 81.7% of patients, respectively. At the minimal lumen area site, the proximal LAD segment showed the smallest lumen [3.5 mm2 (2.5–4.7), P<0.001] and the greatest plaque burden [73.2% (63.0–79.3), P<0.001] compared with the other segments. Also, there was a significant downward trend in the number of IVUS-defined lesions toward the proximal LMCA (P=0.001). At the maximal %NC site, the proximal LAD segment carried the largest necrotic core [32.7% (25.7–40.1), P<0.001] and the most frequent virtual histology thin-cap fibroatheroma (67.6%, P<0.001) among the segments, followed by the proximal LMCA [30.3% (22.3–40.0) and 32.9%, respectively]. Most of the plaques carried, at least, one slice of fibroatheroma in every segment; thus, fibroatheroma distributed in a continuous pattern from the proximal LAD to the proximal LMCA.
In the significant LMCA bifurcation disease, the proximal LAD segment was found to have the smallest lumen, the largest plaque burden, the highest virtual histology thin-cap fibroatheroma rate, and thus presented the most vulnerable characteristics by virtual histology intravascular ultrasound.
aDepartment of Cardiology, Seoul St Mary’s Hospital, The Catholic University of Korea
bDepartment of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
cDepartment of Cardiology, Tokai University School of Medicine, Isehara, Kanagawa, Japan
dCardiovascular Research Foundation, New York, New York, USA
Correspondence to Soo-Jin Kang, MD, PhD, Department of Cardiology, Asan Medical Center, 388-1 Poongnap-dong, Songpa-gu, 138-736 Seoul, South Korea Tel: +82 230 104 812; fax: +82 247 56898; e-mail: email@example.com
Received March 4, 2016
Received in revised form June 19, 2016
Accepted July 3, 2016